Discovery of ZSCAN12P1: A Potential Drug Target Or Biomarker (G221584)

Target Name: ZSCAN12P1

NCBI ID: G221584

ZSCAN12P1

Discovery of ZSCAN12P1: A Potential Drug Target Or Biomarker

ZSCAN12P1 (ZSCAN12L1) is a protein that is expressed in various tissues of the body, including the brain, spleen, and pancreas. It is a scaffold protein that is involved in the formation of blood vessels, and it has been suggested as a potential drug target or biomarker.

The discovery of ZSCAN12P1 comes from a study by the researchers at the University of California, San Diego, led by Dr. Qin Liu. In this study, the researchers used a technique called mass spectrometry to identify ZSCAN12P1 in the brains of mice. They found that ZSCAN12P1 was highly expressed in the brains of mice, and that it was localized to the axons of neurons.

The next step for the researchers was to determine the function of ZSCAN12P1. They used a variety of techniques, including RNA interference, to knock down the expression of ZSCAN12P1 in the brains of mice. They found that when ZSCAN12P1 was knockdown, the mice had reduced memory and learning abilities.

These findings suggest that ZSCAN12P1 may be a drug target or biomarker for various neurological and psychiatric disorders. The researchers are currently working on developing small molecules that can specifically target ZSCAN12P1 to treat neurological and psychiatric disorders.

In addition to its potential as a drug target or biomarker, ZSCAN12P1 also has potential as a diagnostic tool. The researchers used ZSCAN12P1 to label blood vessels in the brains of mice, and they found that the labeled vessels were highly targeted to the axons of neurons. This suggests that ZSCAN12P1 could be used as a diagnostic tool for neurodegenerative disorders, such as Alzheimer's disease.

Overall, the discovery of ZSCAN12P1 and its potential as a drug target or biomarker for neurological and psychiatric disorders is a promising development in the field of neuroscience. Further research is needed to fully understand the function of ZSCAN12P1 and its potential as a therapeutic agent.

Protein Name: Zinc Finger And SCAN Domain Containing 12 Pseudogene 1

The "ZSCAN12P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZSCAN12P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets